Dr. Kelly Halderman is a board-certified Medical Science Liaison with a specialized focus on education, nutrigenomics, and nutraceutical formulation. She holds a Doctorate in Clinical Nutrition (DCN), is a board-certified clinical nutritionist (CCN), and is certified in MethylGenetic Nutrition through the Nutrigenetic Research Institute. Her commitment to advancing healthcare is reflected in her active memberships with leading organizations, including Women in Nutraceuticals, as well as her role as President and Founder of the American Association of Nutraceutical Formulators. She brings extensive experience in nutraceutical science, including the formulation of cutting-edge supplements and the education of consumers, clinicians, and professional organizations on innovative health solutions. She is the author of Phase 2.5 Detox and The Thyroid Debacle, and her research on cellular senescence has been published in the peer-reviewed journal Aging. Her mission is to educate practitioners on the clinical application of nutrition, using tools like genetic evaluation to enable personalized, precision-based care. Her lifelong dedication to health restoration and education underscores her unwavering commitment to advance the field of nutrition and nutrigenomics through science-driven strategies.